Skip to main content
TOOLS
The Morningstar Fund Compare tool quickly evaluates different funds against one another. In addition to Nuveen funds, add any MF, CEF or ETF available from Morningstar. Important information and disclosures are included after you click Generate Report. Please ensure to enable pop-ups in your browser.
The Morningstar Portfolio Review tool compares and analyzes your portfolio holdings. In addition to Nuveen funds, add any MF, CEF or ETF available from Morningstar. Important information and disclosures are included after you click Generate Report. Please ensure to enable pop-ups in your browser.
utility-drawer__mobile-restriction Tools are currently unavailable for use on mobile. Please visit the desktop site.
fund compare tool image
Fund Compare
Quickly evaluate different MFs, CEFs and ETFs against one another
portfolio review tool image
Portfolio Review
Generate a detailed analysis of your portfolio holdings including MFs, CEFs and ETFs
Image of Municipal bond investing ladder tool
Municipal Bond Ladder Tool
Learn how a laddered portfolio may perform in rising rate environments
Powered by Morning star
Welcome to Nuveen
Select your preferred site so we can tailor your experience.
Select Region...
  • Americas
  • Asia Pacific
  • Europe, Middle East, Africa
location select
Select Location...
  • Canada
  • Latin America
  • United States
  • Australia
  • Hong Kong
  • Japan
  • Mainland China
  • Malaysia
  • New Zealand
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Other
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Ireland
  • Italy
  • Luxembourg
  • Middle East
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • Other
location select
Global Cities REIT (GCREIT)
  • Institutional Investor
  • Individual Investor
  • Financial Professional
  • Global Cities REIT (GCREIT)
  • Green Capital
  • Private Capital Income Fund (PCAP)
location select
background-9-90 Corporate Center | Properties

9-90 Corporate Center

9-90 Corporate center front view

9-90 Corporate Center a mortgage which will provide financing for the acquisition and renovation a four-building office/lab campus located in Boston, MA.

The life science property is located 25 miles west of Boston at the intersection of Route 9 and U.S. Interstate 90 in Framingham, Massachusetts.

The Property is currently 81% leased to a tenant roster anchored by life science and technology users, many of which operate their headquarters or other flagship facilities on site.

The mortgage will be a structured financing execution in which the Fund originates a whole loan and then sells the A-Note, retaining the higher yielding B-Note.

The Sponsor’s planned buildout will feature 60% lab / 40% office with both biotechnology and chemical functionality. This buildout will be ideal to attract the type of biotech firms inthe 30-60k SF size range that are currently seeking space in the submarket.
Richard Kimble, Portfolio Manager

Global city:

  • Boston is one of the top life sciences markets in the country, with strong regional employment growth; access to top universities, healthcare systems, and talent; and strong venture capital flowing into the region.
  • Between 2014 and 2017, the Boston-Cambridge market, the No. 1 life sciences cluster in the United States, grew at a faster pace than any other major life sciences cluster. The region’s unparalleled educational institutions, abundance of available funding and top-rated talent have this market well positioned for continued growth.
Sego Lily, GCREIT holding
Explore our global property portfolio

The properties pictured in the presentation represent select holdings at the time of publication and are not meant to represent the entire portfolio. The opinions expressed are reflective of the manager's views at the time of acquisition.

Contact us
Contact us
Back to Top